Article info
PDFEditorial
Taking the ‘Disease’ out of ‘Parkinson’s’: has the disease had its day?
- Correspondence to Dr Paul F Worth, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK; paul.worth{at}addenbrookes.nhs.uk
Citation
Taking the ‘Disease’ out of ‘Parkinson’s’: has the disease had its day?
Publication history
- Accepted November 2, 2018
- First published November 21, 2018.
Online issue publication
January 17, 2019
Article Versions
- Previous version (17 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Parkinson's disease: chameleons and mimics
- Fifty years of progressive supranuclear palsy
- Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
- Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome
- Parkinson’s disease: clinical features and diagnosis
- Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy
- Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes
- The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study